(Z)-1-hydroxymethylene-1-phenylacetone | 68655-09-4

• 分子结构分类: 有机化合物 - 苯类化合物 - 苯和取代衍生物
• 英文名称: (Z)-1-hydroxymethylene-1-phenylacetone
• 英文别名: 2-Acetylphenylacetaldehyd；(Z)-4-hydroxy-3-phenylbut-3-en-2-one
• CAS: 68655-09-4
• 化学式: C₁₀H₁₀O₂
• 分子量: 162.188
• InChiKey: IEKCKXIUVQTQTF-JXMROGBWSA-N

物化性质

• 熔点：
  74-75 °C(Solv: methanol (67-56-1))
• 沸点：
  322.1±42.0 °C(Predicted)
• 密度：
  1.119±0.06 g/cm3(Predicted)

计算性质

• 辛醇/水分配系数(LogP)：
  2
• 重原子数：
  12
• 可旋转键数：
  2
• 环数：
  1.0
• sp3杂化的碳原子比例：
  0.1
• 拓扑面积：
  37.3
• 氢给体数：
  1
• 氢受体数：
  2

反应信息

• 作为反应物：
  描述：

  (Z)-1-hydroxymethylene-1-phenylacetone 、 二乙胺 以96%的产率得到
  参考文献：
  名称：

  BARGAGNA, A.;EVANGELISTI, F.;SCHENONE, P., J. HETEROCYCL. CHEM., 1981, 18, N 1, 111-116

  摘要：

  DOI：
• 作为产物：
  描述：

  trans-2-acetyl-3-phenyloxirane 在 bismuth(lll) trifluoromethanesulfonate 作用下， 以 二氯甲烷 为溶剂， 反应 0.33h， 以89%的产率得到(Z)-1-hydroxymethylene-1-phenylacetone
  参考文献：
  名称：

  使用三氟甲磺酸铋将芳基取代的环氧化物重排为醛和酮的简便有效方法

  摘要：

  芳基取代的环氧化物在0.01–0.1 mol％Bi（OTf）3 · x H 2 O的存在下会经历平滑的重排。重排具有芳基取代的环氧化物的区域选择性，并且产物由苄基CO键断裂而产生。该方法的高催化性质以及该试剂相对无毒，易于操作和廉价的事实，使其成为更具腐蚀性和毒性的路易斯酸（例如目前用于BF 3 ·Et 2 O）的有吸引力的替代品。引起环氧化物重排。

  DOI：

  10.1016/s0040-4039(01)01519-2

文献信息

• 5,6-Benzo analogues or prostaglandin E
  申请人：Miles Laboratories, Inc.

  公开号：US04096336A1

  公开（公告）日：1978-06-20

  Disclosed are prostaglandin analogues having the structural formula, ##STR1## in which: T is selected from the group consisting of carboxyl, alkoxycarbonyl or cyano; M is selected from the group consisting of carbonyl, R-hydroxymethylene or S-hydroxymethylene; L is selected from the group consisting of methylene or methine, provided L is methine only if J is methine; J is selected from the group consisting of methylene, ethylene, R-hydroxymethylene, S-hydroxymethylene or methine, provided J is methine only if L is methine; W is selected from the group consisting of --CH.sub.2 --CH-- or trans --CH.dbd.C--; T.sub.1 and T.sub.2 are attached to adjacent carbon atoms; T.sub.1 is selected from the group consisting of hydrogen or phenyl, provided T.sub.1 is phenyl only if T.sub.2 is lower alkyl; T.sub.2 is selected from the group consisting of n-pentyl or lower alkyl, provided T.sub.2 is lower alkyl only if T.sub.1 is phenyl; Or T.sub.1 and T.sub.2 are joined together to form an alkylene group of 4 or 6 carbon atoms. Also disclosed are methods for preparing such prostaglandin analogues.

  本文披露了具有下列结构式的前列腺素类似物：其中：T选自羧基、烷氧羰基或氰基组成的群；M选自羰基、R-羟甲亚甲基或S-羟甲亚甲基组成的群；L选自亚甲基或亚甲烷基组成的群，只有在J为亚甲基时L才为亚甲烷基；J选自亚甲基、乙烯基、R-羟甲亚甲基、S-羟甲亚甲基或亚甲基组成的群，只有在L为亚甲烷基时J才为亚甲基；W选自--CH.sub.2 --CH--或trans --CH.dbd.C--组成的群；T.sub.1和T.sub.2连接到相邻的碳原子上；T.sub.1选自氢或苯基，只有当T.sub.2为较低的烷基时T.sub.1才为苯基；T.sub.2选自正戊基或较低的烷基，只有当T.sub.1为苯基时T.sub.2才为较低的烷基；或者T.sub.1和T.sub.2连接在一起形成含有4个或6个碳原子的烷基基团。还公开了制备这种前列腺素类似物的方法。
• 5,6-Benzo analogues of prostaglandin E
  申请人：Miles Laboratories, Inc.

  公开号：US04097516A1

  公开（公告）日：1978-06-27

  Disclosed are prostaglandin analogues having the structural formula, ##STR1## in which: T is selected from the group consisting of carboxyl, alkoxycarbonyl or cyano; M is selected from the group consisting of carbonyl, R-hydroxymethylene or S-hydroxymethylene; L is selected from the group consisting of methylene or methine, provided L is methine only if J is methine; J is selected from the group consisting of methylene, ethylene, R-hydroxymethylene, S-hydroxymethylene or methine, provided J is methine only if L is methine; W is selected from the group consisting of --CH.sub.2 --CH-- or trans --CH.dbd.C--; T.sub.1 and T.sub.2 are attached to adjacent carbon atoms; T.sub.1 is selected from the group consisting of hydrogen or phenyl, provided T.sub.1 is phenyl only if T.sub.2 is lower alkyl; T.sub.2 is selected from the group consisting of n-pentyl or lower alkyl, provided T.sub.2 is lower alkyl only if T.sub.1 is phenyl; Or T.sub.1 and T.sub.2 are joined together to form an alkylene group of 4 or 6 carbon atoms. Also disclosed are methods for preparing such prostaglandin analogues.

  揭示了具有结构式##STR1##的前列腺素类似物，其中：T从羧基，烷氧羰基或氰基组成的群体中选择；M从羰基，R-羟甲基或S-羟甲基组成的群体中选择；L从亚甲基或甲烷基组成的群体中选择，前提是只有当J为亚甲基时，L才是亚甲基；J从亚甲基，乙烯基，R-羟甲基，S-羟甲基或甲烷基组成的群体中选择，前提是只有当L为亚甲基时，J才是亚甲基；W从--CH.sub.2 --CH--或trans --CH.dbd.C--组成的群体中选择；T.sub.1和T.sub.2连接到相邻的碳原子上；T.sub.1从氢或苯基组成的群体中选择，前提是只有当T.sub.2为较低烷基时，T.sub.1才是苯基；T.sub.2从n-戊基或较低烷基组成的群体中选择，前提是只有当T.sub.1为苯基时，T.sub.2才是较低烷基；或者T.sub.1和T.sub.2结合在一起形成4或6个碳原子的烷基基团。还公开了制备这种前列腺素类似物的方法。
• 5,6-Benzo analogues of prostaglandin
  申请人：Miles Laboratories, Inc.

  公开号：US04238623A1

  公开（公告）日：1980-12-09

  Disclosed are prostaglandin analogues having the structural formula, ##STR1## in which: T is selected from the group consisting of carboxyl, alkoxycarbonyl or cyano; M is selected from the group consisting of carbonyl, R-hydroxymethylene or S-hydroxymethylene; L is selected from the group consisting of methylene or methine, provided L is methine only if J is methine; J is selected from the group consisting of methylene, ethylene, R-hydroxymethylene, S-hydroxymethylene or methine, provided J is methine only if L is methine; W is selected from the group consisting of ##STR2## T.sub.1 and T.sub.2 are attached to adjacent carbon atoms; T.sub.1 is selected from the group consisting of hydrogen or phenyl, provided T.sub.1 is phenyl only if T.sub.2 is lower alkyl; T.sub.2 is selected from the group consisting of n-pentyl or lower alkyl, provided T.sub.2 is lower alkyl only if T.sub.1 is phenyl; or T.sub.1 and T.sub.2 are joined together to form an alkylene group of 4 or 6 carbon atoms. Also disclosed are methods for preparing such prostaglandin analogues.

  本发明涉及具有结构式##STR1##的前列腺素类似物，其中：T选自羧基，烷氧羰基或氰基的群；M选自羰基，R-羟甲基或S-羟甲基的群；L选自亚甲基或亚胺基的群，仅当J为亚胺基时，L才为亚胺基；J选自亚甲基，乙烯基，R-羟甲基，S-羟甲基或亚胺基的群，仅当L为亚胺基时，J才为亚胺基；W选自##STR2##的群；T.sub.1和T.sub.2连接到相邻的碳原子上；T.sub.1选自氢或苯基的群，仅当T.sub.2为较低烷基时，T.sub.1才为苯基；T.sub.2选自正戊基或较低烷基的群，仅当T.sub.1为苯基时，T.sub.2才为较低烷基；或T.sub.1和T.sub.2连接在一起形成4或6个碳原子的烷基。还公开了制备这种前列腺素类似物的方法。
• Cyclohexanone-5,6-benzo analogues of prostaglandin
  申请人：Miles Laboratories, Inc.

  公开号：US04100352A1

  公开（公告）日：1978-07-11

  Disclosed are prostaglandin analogues having the structural formula, ##STR1## in which: T is selected from the group consisting of carboxyl, alkoxycarbonyl or cyano; M is selected from the group consisting of carbonyl, R-hydroxymethylene or S-hydroxymethylene; L is selected from the group consisting of methylene or methine, provided L is methine only if J is methine; J is selected from the group consisting of methylene, ethylene, R-hydroxymethylene, S-hydroxymethylene or methine, provided J is methine only if L is methine; W is selected from the group consisting of ##STR2## T.sub.1 and T.sub.2 are attached to adjacent carbon atoms; T.sub.1 is selected from the group consisting of hydrogen or phenyl, provided T.sub.1 is phenyl only if T.sub.2 is lower alkyl; T.sub.2 is selected from the group consisting of n-pentyl or lower alkyl, provided T.sub.2 is lower alkyl only if T.sub.1 is phenyl; Or T.sub.1 and T.sub.2 are joined together to form an alkylene group of 4 or 6 carbon atoms. Also disclosed are methods for preparing such prostaglandin analogues.

  本发明涉及结构式为##STR1##的前列腺素类似物，其中：T选自羧基，烷氧羰基或氰基的群组中；M选自羰基，R-羟甲基或S-羟甲基的群组中；L选自亚甲基或亚胺基的群组中，仅当J为亚胺基时，L才为亚胺基；J选自亚甲基，乙烯基，R-羟甲基，S-羟甲基或亚胺基的群组中，仅当L为亚胺基时，J才为亚胺基；W选自##STR2##的群组中；T.sub.1和T.sub.2附着在相邻的碳原子上；T.sub.1选自氢或苯基的群组中，仅当T.sub.2为较低的烷基时，T.sub.1才为苯基；T.sub.2选自正戊基或较低的烷基的群组中，仅当T.sub.1为苯基时，T.sub.2才为较低的烷基；或T.sub.1和T.sub.2结合形成4或6个碳原子的烷基。本发明还涉及制备这种前列腺素类似物的方法。
• 5,6-Benza analogues of prostaglandin F
  申请人：Miles Laboratories, Inc.

  公开号：US04100353A1

  公开（公告）日：1978-07-11

  Disclosed are prostaglandin analogues having the structural formula, ##STR1## in which: T is selected from the group consisting of carboxyl, alkoxycarbonyl or cyano; M is selected from the group consisting of carbonyl, R-hydroxymethylene or S-hydroxymethylene; L is selected from the group consisting of methylene or methine, provided L is methine only if J is methine; J is selected from the group consisting of methylene, ethylene, R-hydroxymethylene, S-hydroxymethylene or methine, provided J is methine only if L is methine; W is selected from the group consisting of ##STR2## T.sub.1 and T.sub.2 are attached to adjacent carbon atoms; T.sub.1 is selected from the group consisting of hydrogen or phenyl, provided T.sub.1 is phenyl only if T.sub.2 is lower alkyl; T.sub.2 is selected from the group consisting of n-pentyl or lower alkyl, provided T.sub.2 is lower alkyl only if T.sub.1 is phenyl; or T.sub.1 and T.sub.2 are joined together to form an alkylene group of 4 to 6 carbon atoms. Also disclosed are methods for preparing such prostaglandin analogues.

  本发明涉及一种具有以下结构式的前列腺素类似物：##STR1## 其中：T选自羧基，烷氧羰基或氰基的群；M选自羰基，R-羟甲基或S-羟甲基的群；L选自亚甲基或亚胺基的群，仅当J为亚胺基时，L才为亚胺基；J选自甲基，乙烯基，R-羟甲基，S-羟甲基或亚甲基的群，仅当L为亚甲基时，J才为亚甲基；W选自##STR2## T1和T2连接到相邻的碳原子上；T1选自氢或苯基的群，仅当T2为较低烷基时，T1才为苯基；T2选自n-戊基或较低烷基的群，仅当T1为苯基时，T2才为较低烷基；或T1和T2连接在一起形成4至6个碳原子的烷基。本发明还涉及制备这种前列腺素类似物的方法。